Sorrento Therapeutics (NASDAQ:SRNE) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE) in a report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Sorrento Therapeutics Stock Performance

Sorrento Therapeutics stock opened at $0.01 on Monday. The stock has a fifty day moving average of $0.02 and a 200 day moving average of $0.05. Sorrento Therapeutics has a one year low of $0.00 and a one year high of $0.42.

Sorrento Therapeutics Company Profile

Sorrento Therapeutics, Inc engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates.